91 related articles for article (PubMed ID: 29851841)
1. When dysphoria is not a primary mental state: A case report of the role of the aromatic L-aminoacid decarboxylase.
Portaro S; Gugliandolo A; Scionti D; Cammaroto S; Morabito R; Leonardi S; Fraggetta F; Bramanti P; Mazzon E
Medicine (Baltimore); 2018 Jun; 97(22):e10953. PubMed ID: 29851841
[TBL] [Abstract][Full Text] [Related]
2. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency.
Wassenberg T; Molero-Luis M; Jeltsch K; Hoffmann GF; Assmann B; Blau N; Garcia-Cazorla A; Artuch R; Pons R; Pearson TS; Leuzzi V; Mastrangelo M; Pearl PL; Lee WT; Kurian MA; Heales S; Flint L; Verbeek M; Willemsen M; Opladen T
Orphanet J Rare Dis; 2017 Jan; 12(1):12. PubMed ID: 28100251
[TBL] [Abstract][Full Text] [Related]
3. Aromatic L-Amino Acid Decarboxylase Deficiency: A Genetic Screening in Sicilian Patients with Neurological Disorders.
Santa Paola S; Di Blasi FD; Borgione E; Lo Giudice M; Giuliano M; Pettinato R; Di Stefano V; Brighina F; Lupica A; Scuderi C
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275615
[TBL] [Abstract][Full Text] [Related]
4. Selective Serotonin Reuptake Inhibitor Treatment Post Gene Therapy for an Ultrarare Neurometabolic Disorder (AADC Deficiency).
Baribeau DA; Vorstman JAS; Pearson TS
J Am Acad Child Adolesc Psychiatry; 2024 Jun; 63(6):571-573. PubMed ID: 38460745
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of DDC genotypes in patients with aromatic L-amino acid decarboxylase (AADC) deficiency and in silico prediction of structural protein changes.
Himmelreich N; Bertoldi M; Alfadhel M; Alghamdi MA; Anikster Y; Bao X; Bashiri FA; Zeev BB; Bisello G; Ceylan AC; Chien YH; Choy YS; Elsea SH; Flint L; García-Cazorla À; Gijavanekar C; Gümüş EY; Hamad MH; Hişmi B; Honzik T; Hübschmann OK; Hwu WL; Ibáñez-Micó S; Jeltsch K; Juliá-Palacios N; Kasapkara ÇS; Kurian MA; Kusmierska K; Liu N; Ngu LH; Odom JD; Ong WP; Opladen T; Oppeboen M; Pearl PL; Pérez B; Pons R; Rygiel AM; Shien TE; Spaull R; Sykut-Cegielska J; Tabarki B; Tangeraas T; Thöny B; Wassenberg T; Wen Y; Yakob Y; Yin JGC; Zeman J; Blau N
Mol Genet Metab; 2023 Jul; 139(3):107624. PubMed ID: 37348148
[TBL] [Abstract][Full Text] [Related]
6. Detection of hidden intronic DDC variant in aromatic L-amino acid decarboxylase deficiency by adaptive sampling.
Koshimizu E; Kato M; Misawa K; Uchiyama Y; Tsuchida N; Hamanaka K; Fujita A; Mizuguchi T; Miyatake S; Matsumoto N
J Hum Genet; 2024 Apr; 69(3-4):153-157. PubMed ID: 38216729
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for aromatic L-amino acid decarboxylase deficiency: Requirements for safe application and knowledge-generating follow-up.
Roubertie A; Opladen T; Brennenstuhl H; Kuseyri Hübschmann O; Flint L; Willemsen MA; Leuzzi V; Cazorla AG; Kurian MA; François-Heude MC; Hwu P; Zeev BB; Kiening K; Roujeau T; Pons R; Pearson TS
J Inherit Metab Dis; 2024 May; 47(3):463-475. PubMed ID: 37402126
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative Etiology of Aromatic L-Amino Acid Decarboxylase Deficiency: a Novel Concept for Expanding Treatment Strategies.
Sternberg Z
Mol Neurobiol; 2024 May; 61(5):2996-3018. PubMed ID: 37953352
[TBL] [Abstract][Full Text] [Related]
9. Novel presentation of AADC deficiency as a mild phenotype with exercise-induced dystonic crises: A case report.
Thys L; Meuwissen M; Janssens K; Beysen D
Heliyon; 2024 Jan; 10(1):e23746. PubMed ID: 38192810
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 3-
Kubaski F; Herbst ZM; Pereira DAA; Silva C; Chen C; Hwu PWL; van der Linden H; Lourenço CM; Giugliani R
Mol Genet Metab Rep; 2021 Jun; 27():100744. PubMed ID: 33763332
[TBL] [Abstract][Full Text] [Related]
11. Case report: Childhood epilepsy and borderline intellectual functioning hiding an AADC deficiency disorder associated with compound heterozygous
Cursio I; Siliquini S; Carducci C; Bisello G; Mastrangelo M; Leuzzi V; Bertoldi M; Marini C
Front Neurol; 2023; 14():1284339. PubMed ID: 38116105
[TBL] [Abstract][Full Text] [Related]
12. A position statement on the post gene-therapy rehabilitation of aromatic I-amino acid decarboxylase deficiency patients.
Lee HM; Mercimek-Andrews S; Horvath G; Marchese D; Poulin RE; Krolick A; Tierney KL; Turna J; Wei J; Hwu WL
Orphanet J Rare Dis; 2024 Jan; 19(1):17. PubMed ID: 38238766
[TBL] [Abstract][Full Text] [Related]
13. Carrier frequency and incidence of aromatic L-amino acid decarboxylase deficiency: a gnomAD-based study.
Park JE; Lee T; Ha K; Cho EH; Ki CS
Pediatr Res; 2023 Nov; 94(5):1764-1770. PubMed ID: 37286773
[TBL] [Abstract][Full Text] [Related]
14. Automatically pre-screening patients for the rare disease aromatic l-amino acid decarboxylase deficiency using knowledge engineering, natural language processing, and machine learning on a large EHR population.
Cohen AM; Kaner J; Miller R; Kopesky JW; Hersh W
J Am Med Inform Assoc; 2024 Feb; 31(3):692-704. PubMed ID: 38134953
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for neurotransmitter-related disorders.
Chu WS; Ng J; Waddington SN; Kurian MA
J Inherit Metab Dis; 2024 Jan; 47(1):176-191. PubMed ID: 38221762
[TBL] [Abstract][Full Text] [Related]
16. Novel SLC18A2 Variant in Infantile Dystonia-Parkinsonism Type 2.
Kaasalainen S; Arikka H; Martikainen MH; Kaasinen V
Case Rep Neurol Med; 2024; 2024():4767647. PubMed ID: 38716424
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Herrmann M
MMW Fortschr Med; 2023 Oct; 165(17):66. PubMed ID: 37759032
[No Abstract] [Full Text] [Related]
18. The Briefcase She Carried.
Athanasios A; Radice-Vella G
J Palliat Med; 2023 Mar; 26(3):444. PubMed ID: 36862835
[No Abstract] [Full Text] [Related]
19. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971
[TBL] [Abstract][Full Text] [Related]
20. Erenumab (Aimovig) for migraine prevention.
Med Lett Drugs Ther; 2018 Jun; 60(1549):101-103. PubMed ID: 29913472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
